SCHEMBL3789307

SCHEMBL3789307

Clc1cc(Oc2ccccc2)cc(Oc2ccccc2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 5/20 0.60
TSHR P16473 1/20 0.60
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
NLRP3 Q96P20 1/20 0.52
CYP1A2 P05177 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
CYP3A4 P08684 1/20 0.48
PGR P06401 1/20 0.47
MAOB P27338 1/20 0.46
NR1H2 P55055 1/20 0.46
BAX Q07812 1/20 0.46
MAOA P21397 1/20 0.46
GSTP1 P09211 1/20 0.43
GAA P10253 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MITF O75030 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL811027 0.95 LTA4H (0.60) LTA4HTSHRMEN1KMT2ANPC1
SCHEMBL13119751 0.89 LTA4H (0.59) LTA4HTSHRMEN1KMT2ANPC1
SCHEMBL11745259 0.87 LTA4H (0.80) LTA4HTSHRMEN1KMT2ANPC1
SCHEMBL6545667 0.87 LTA4H (0.80) LTA4HTSHRMEN1KMT2ANPC1
SCHEMBL30543010 0.85 TERT (0.53) TSHRMEN1KMT2ACYP1A2CYP2C9
SCHEMBL10772416 0.85 LTA4H (0.54) LTA4HTSHRMEN1KMT2ANPC1
SCHEMBL3791201 0.85 MEN1 (0.63) LTA4HTSHRMEN1KMT2ANPC1
SCHEMBL10549494 0.85 LTA4H (0.48) LTA4HTSHRMEN1KMT2ANPC1
SCHEMBL15902880 0.85 LTA4H (0.48) LTA4HTSHRMEN1KMT2ANPC1
SCHEMBL3790523 0.83 LTA4H (0.57) LTA4HTSHRMEN1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 LTA4H 2263/4885TSHR 1688/4885MEN1 174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.